258 related articles for article (PubMed ID: 32596739)
1. Epidemiology and antimicrobial susceptibility of Staphylococcus lugdunensis in a Greek tertiary-care hospital.
Kachrimanidou M; Malliou P; Meletis G; Netsika F; Mavrovouniotis I; Protonotariou E; Skoura L
New Microbiol; 2020 Jul; 43(3):133-135. PubMed ID: 32596739
[TBL] [Abstract][Full Text] [Related]
2. Abscesses and wound infections due to Staphylococcus lugdunensis: report of 16 cases.
Papapetropoulos N; Papapetropoulou M; Vantarakis A
Infection; 2013 Apr; 41(2):525-8. PubMed ID: 23242962
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis.
McHardy IH; Veltman J; Hindler J; Bruxvoort K; Carvalho MM; Humphries RM
J Clin Microbiol; 2017 Feb; 55(2):585-595. PubMed ID: 27927926
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States.
Farrell DJ; Mendes RE; Bensaci M
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):85-88. PubMed ID: 30314652
[TBL] [Abstract][Full Text] [Related]
5. Frequency, clinical manifestations, and outcomes of Staphylococcus lugdunensis Bacteremia in children.
Sato M; Kubota N; Horiuchi A; Kasai M; Minami K; Matsui H
J Infect Chemother; 2016 May; 22(5):298-302. PubMed ID: 26898664
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options.
Taha L; Stegger M; Söderquist B
Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1449-1455. PubMed ID: 31144243
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan.
Lin JF; Cheng CW; Kuo AJ; Liu TP; Yang CC; Huang CT; Lee MH; Lu JJ
J Microbiol Immunol Infect; 2015 Aug; 48(4):406-12. PubMed ID: 24529852
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance and virulence characterization of Staphylococcus aureus and coagulase-negative staphylococci from imported beef meat.
Osman K; Alvarez-Ordóñez A; Ruiz L; Badr J; ElHofy F; Al-Maary KS; Moussa IMI; Hessain AM; Orabi A; Saad A; Elhadidy M
Ann Clin Microbiol Antimicrob; 2017 May; 16(1):35. PubMed ID: 28486995
[TBL] [Abstract][Full Text] [Related]
10. [Staphylococcus lugdunensis infection: report of 44 cases].
Betrán A; Cebollada R; Lavilla MJ; Torres L
Rev Chilena Infectol; 2022 Jun; 39(3):254-259. PubMed ID: 36156686
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological characterization of Staphylococcus lugdunensis isolates obtained from clinical specimens in a hospital in China.
Liu C; Shen D; Guo J; Wang K; Wang H; Yan Z; Chen R; Ye L
BMC Microbiol; 2012 Aug; 12():168. PubMed ID: 22866997
[TBL] [Abstract][Full Text] [Related]
12. Emergence of oxacillin-resistant Staphylococcus lugdunensis carrying staphylococcal cassette chromosome mec type V in central Taiwan.
Yen TY; Sung YJ; Lin HC; Peng CT; Tien N; Hwang KP; Lu JJ
J Microbiol Immunol Infect; 2016 Dec; 49(6):885-891. PubMed ID: 25648670
[TBL] [Abstract][Full Text] [Related]
13. Unusually virulent coagulase-negative Staphylococcus lugdunensis is frequently associated with infective endocarditis: a Waikato series of patients.
Liang M; Mansell C; Wade C; Fisher R; Devlin G
N Z Med J; 2012 May; 125(1354):51-9. PubMed ID: 22595924
[TBL] [Abstract][Full Text] [Related]
14. Persistence of a major endemic clone of oxacillin-resistant Staphylococcus lugdunensis sequence type 6 at a tertiary medical centre in northern Taiwan.
Cheng CW; Liu TP; Yeh CF; Lee MH; Chang SC; Lu JJ
Int J Infect Dis; 2015 Jul; 36():72-7. PubMed ID: 26051975
[TBL] [Abstract][Full Text] [Related]
15. Virulence factors among Staphylococcus lugdunensis are associated with infection sites and clonal spread.
Giormezis N; Kolonitsiou F; Makri A; Vogiatzi A; Christofidou M; Anastassiou ED; Spiliopoulou I
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):773-8. PubMed ID: 25471196
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center.
Nesher L; Tarrand J; Chemaly RF; Rolston KV
Support Care Cancer; 2017 Apr; 25(4):1063-1069. PubMed ID: 27885468
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis.
Lourtet-Hascoët J; Bicart-See A; Félicé MP; Giordano G; Bonnet E
Int J Infect Dis; 2016 Oct; 51():56-61. PubMed ID: 27609028
[TBL] [Abstract][Full Text] [Related]
18. The species distribution, antimicrobial resistance and risk factors for poor outcome of coagulase-negative staphylococci bacteraemia in China.
Cui J; Liang Z; Mo Z; Zhang J
Antimicrob Resist Infect Control; 2019; 8():65. PubMed ID: 31044070
[TBL] [Abstract][Full Text] [Related]
19. Efficient Killing of Planktonic and Biofilm-Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128.
Poonacha N; Nair S; Desai S; Tuppad D; Hiremath D; Mohan T; Vipra A; Sharma U
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559263
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of infective endocarditis with Staphylococcus lugdunensis bacteremia: A retrospective cohort study and systematic review.
Non LR; Santos CA
J Infect; 2017 Feb; 74(2):179-186. PubMed ID: 27777118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
